04 Jan 2024 | 04:00 PM GMT

How to Scale Partnerships Between Lifesciences and Digital Health Companies?

Participants:

Piotr Sokolowski Chief Medtech StrategistS3 Connected Health
Piotr Sokolowski
Chief Medtech StrategistS3 Connected Health
Melinda Decker AdvisorPlexus Ventures
Melinda Decker
AdvisorPlexus Ventures
Arlindo Ferreira Senior Medical DirectorResilience Care
Arlindo Ferreira
Senior Medical DirectorResilience Care
Ciarán Friel Behavioral ScientistNorthwell Health
Ciarán Friel
Behavioral ScientistNorthwell Health
Denise Leid Business InnovationBoehringer Ingelheim Pharmaceuticals Inc Ridgefield CT
Denise Leid
Business InnovationBoehringer Ingelheim Pharmaceuticals Inc Ridgefield CT
Elias Abou Zeid PrincipalNovo Nordisk
Elias Abou Zeid
PrincipalNovo Nordisk
Elias Abou Zeid Principal Data Scientist Novo Nordisk
Elias Abou Zeid
Principal Data Scientist Novo Nordisk
Gabriele Tundo PartnerPlexus Ventures
Gabriele Tundo
PartnerPlexus Ventures
Jon Melnick Engagement ManagerZS Associates
Jon Melnick
Engagement ManagerZS Associates
Kelsey Yevak Associate DirectorTakeda Pharmaceuticals
Kelsey Yevak
Associate DirectorTakeda Pharmaceuticals
Lucas Camedescasse VP Life SciencesResilience Care
Lucas Camedescasse
VP Life SciencesResilience Care
Malin Johansson Vice PresidentNovo Nordisk
Malin Johansson
Vice PresidentNovo Nordisk
Ralph Morales III Managing DirectorShokunin Ventures
Ralph Morales III
Managing DirectorShokunin Ventures
Sheena Dempsey Chief Solutions Officer Indivi
Sheena Dempsey
Chief Solutions Officer Indivi
Susanne Gruber Strategic Advisor, Interim ExecutiveIgnited Vision
Susanne Gruber
Strategic Advisor, Interim ExecutiveIgnited Vision
Taiba Quraishi Innovation Accelerator LeadAlexion Pharmaceuticals
Taiba Quraishi
Innovation Accelerator LeadAlexion Pharmaceuticals
Thibault Demoures Business Development OfficerHealthAnea
Thibault Demoures
Business Development OfficerHealthAnea

About this Meeting

Pharma companies have identified technology as an opportunity to deliver more value to their patients and clinicians and differentiate from other competitors. While they are eager to bring this strategy to life at scale, partnerships with pharma are still a tough path for digital health companies beyond pilot initiatives. This meeting will deep dive into pharma and digital health partnerships and how they can be successful at scale. Join us in a peer-to-peer conversation where we will discuss the following: 


  • What drives digital health companies and pharma to partner up? What can each side provide for the other in the short and medium term? 

  • How to go beyond pilots and build long-term sustainable partnerships? 

  • How can pharma seamlessly integrate these companies into their business model and company strategy? 

  • Once a partnership deal is closed and we have a clear roadmap on the table, what comes next? How do we ensure the partnership will succeed over a longer time frame? 

  • The future of pharma working with digital health companies.


We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.